Quick Answer
Organogenesis Holdings Inc. reported Gross Profit of $366.30 million for fiscal year 2024.
Organogenesis Holdings Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $366.30M | +12.1% |
| 2023 | $326.66M | -5.6% |
| 2022 | $345.87M | -2.1% |
| 2021 | $353.16M | +40.7% |
| 2020 | $250.98M | +35.6% |
| 2019 | $185.03M | +48.5% |
| 2018 | $124.64M | -9.2% |
| 2017 | $137.29M | +51.6% |
| 2016 | $90.53M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $62.97M | -22.5% | -28.8% |
| September 30, 2024 | $88.38M | +6.8% | -12.5% |
| June 30, 2024 | $101.04M | +11.0% | +24.3% |
| March 31, 2024 | $81.28M | +0.3% | -1.8% |
| September 30, 2023 | $82.74M | -8.8% | -9.1% |
| June 30, 2023 | $91.00M | -4.0% | +12.3% |
| March 31, 2023 | $81.03M | +12.5% | -10.6% |
| September 30, 2022 | $90.68M | +3.5% | -4.3% |
- Organogenesis Holdings Inc. showed an increase of +12.1% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2024 period, Organogenesis Holdings Inc.’s gross profit has grown by 304.6% (from $90.53 million to $366.30 million).
- The most recent figure is from Organogenesis Holdings Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: